These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7021412)

  • 21. Increased prostaglandin E2 excretion with oral kallikrein treatment in hypertensive and normotensive subjects.
    Muller HM; Overlack A; Stumpe KO; Kollock R; Ressel C
    Adv Exp Med Biol; 1983; 156 (Pt B)():1005-9. PubMed ID: 6574693
    [No Abstract]   [Full Text] [Related]  

  • 22. Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen.
    Radack KL; Deck CC; Bloomfield SS
    Ann Intern Med; 1987 Nov; 107(5):628-35. PubMed ID: 2889416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of isradipine and spirapril as monotherapy and combined therapy on blood pressure, renal hemodynamics, natriuresis, and urinary kallikrein in hypertensive nephropathy.
    Maccariello ER; Genelhu de Abreu Fagundes V; Francischetti EA
    Am J Hypertens; 1997 May; 10(5 Pt 1):541-5. PubMed ID: 9160765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary kallikrein excretion is low in malignant essential hypertension.
    Hilme E; Herlitz H; Gyzander E; Hansson L
    J Hypertens; 1992 Aug; 10(8):869-74. PubMed ID: 1325521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of oral potassium on urinary kallikrein excretion in essential hypertension.
    Murakami E; Hiwada K; Kokubu T; Imamura Y
    Adv Exp Med Biol; 1989; 247B():133-7. PubMed ID: 2610052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats.
    Ideishi M; Miura S; Sakai T; Sasaguri M; Misumi Y; Arakawa K
    J Hypertens; 1994 Jun; 12(6):653-61. PubMed ID: 7963490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of magnesium lithospermate B in rats with sodium-induced hypertension and renal failure.
    Yokozawa T; Lee TW; Oura H; Nonaka G; Nishioka I
    Nephron; 1992; 60(4):460-5. PubMed ID: 1584322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary kallikrein activity and renal vascular resistance in the antihypertensive response to thiazide diuretics.
    O'Connor DT; Preston RA; Mitas JA; Frigon RP; Stone RA
    Hypertension; 1981; 3(1):139-47. PubMed ID: 6907170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potassium supplementation lowers blood pressure and increases urinary kallikrein in essential hypertensives.
    Valdés G; Vio CP; Montero J; Avendaño R
    J Hum Hypertens; 1991 Apr; 5(2):91-6. PubMed ID: 2072372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kallikrein-kinin system and blood pressure sensitivity to salt.
    Madeddu P; Varoni MV; Demontis MP; Chao J; Simson JA; Glorioso N; Anania V
    Hypertension; 1997 Jan; 29(1 Pt 2):471-7. PubMed ID: 9039144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
    Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of prostaglandin synthesis by indomethacin interacts with the antihypertensive effect of atenolol.
    Ylitalo P; Pitkäjärvi T; Pyykönen ML; Nurmi AK; Seppälä E; Vapaatalo H
    Clin Pharmacol Ther; 1985 Oct; 38(4):443-9. PubMed ID: 3899459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with terazosin administered in combination with other antihypertensive agents.
    Chrysant SG
    Am J Med; 1986 May; 80(5B):55-61. PubMed ID: 2872808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Celiprolol in systemic hypertension.
    Frishman WH; Flamenbaum W; Schoenberger J; Schwartz GL; Vidt DG; Neri GS; Greenberg S; Lazar E; Godfrey JC; Stevenson A
    Am J Cardiol; 1989 Apr; 63(12):839-42. PubMed ID: 2522723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketanserin in essential hypertension: a double-blind, placebo-controlled study.
    Cameron HA; Ramsay LE
    Postgrad Med J; 1985 Jul; 61(717):583-6. PubMed ID: 3161013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
    Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
    Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of oral L-arginine supplementation on blood pressure: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Dong JY; Qin LQ; Zhang Z; Zhao Y; Wang J; Arigoni F; Zhang W
    Am Heart J; 2011 Dec; 162(6):959-65. PubMed ID: 22137067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of kallikrein in the antihypertensive response to furosemide in essential hypertension.
    Olshan AR; O'Connor DT; Preston RA; Frigon RP; Stone RA
    J Cardiovasc Pharmacol; 1981; 3(1):161-7. PubMed ID: 6160345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary kallikrein excretion in chronic renal failure: relationship to blood pressure and the acute effect of captopril.
    Cumming AD; Lambie AT
    Ren Fail; 1987-1988; 10(3-4):161-7. PubMed ID: 3332725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Renal kallikrein-kinin system and control of blood pressure (author's transl)].
    Distler A; Wolff HP
    Klin Wochenschr; 1979 Oct; 57(19):1037-45. PubMed ID: 392177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.